Balanced news tone
News Sentiment
MBOT sentiment intelligence
Microbot Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
61
Balanced news tone
50 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-3.3% over one week, -3.8% over four weeks, trend inactive, and near fair-value range.
Microbot Medical Inc (MBOT) Risk Assessment: Volatility, Financial Risk & Investment Risk
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-3.3%
Price reacting lower
Trend fit
Trend inactive
-3.8% over four weeks
Fair value
-2.4%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
26
Neutral
21
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
[8-K] Microbot Medical Inc. Reports Material Event | MBOT 8-K Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 13:56
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Doctors using Microbot’s LIBERTY robot to address article claims
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 12:30
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Robot-guided prostate, knee and liver procedures for Microbot's LIBERTY
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Stock Titan
Modern Healthcare News
Direct company coverage
‘Glimmers of hope’ seen for insurers as medical costs abate
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Modern Healthcare News
Market source
Direct company coverage
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Number of shareholders of Microbot Medical Inc. – NASDAQ:MBOT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 May 2026 11:06
- Source
- TradingView
Stock Titan
Direct company coverage
Microbot adds EMEA sales chief as it targets Europe’s 2.3M procedures
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Microbot Medical Begins Full U.S. Launch of LIBERTY System
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
Investing.com
Direct company coverage
H.C. Wainwright reiterates Microbot Medical stock rating on full market release
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 14 Apr 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
Microbot takes its U.S.-cleared vascular robot to Needham investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stock Titan
GuruFocus
Direct company coverage
Microbot Medical (MBOT) Expands LIBERTY Robot System Release in U.S.
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- GuruFocus
Stock Titan
Direct company coverage
Microbot Medical (MBOT) files ATM to raise up to $39.2M for LIBERTY® development
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Apr 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Peer-reviewed LIBERTY study supports Microbot Medical (NASDAQ: MBOT) launch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Stock Titan
simplywall.st
Direct company coverage
Assessing Microbot Medical (MBOT) Valuation As LIBERTY Robotic System Advances Toward Full Market Release
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Feb 2026 08:00
- Source
- simplywall.st
Investing.com
Direct company coverage
Microbot Medical launches LIBERTY robotic system in limited U.S. release
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Nov 2025 08:00
- Source
- Investing.com